Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 8:14 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 365 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obsessive Compulsive Disorder (OCD) Clear all

Conditions: Anxiety
Interventions: Mayo Clinic Anxiety Coach, Treatment as Usual; Device · Other
Lead sponsor: Stephen Whiteside; Other
Eligibility: 7 Years to 17 Years
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obsessive Compulsive Disorder (OCD)
Interventions: CBT for pediatric OCD; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 8 Years to 16 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Obsessive-compulsive Disorders and Symptoms in Children
Interventions: Cognitive Behavioral Therapy, Community Referral as appropriate; Behavioral · Other
Lead sponsor: University of Michigan; Other
Eligibility: 6 Years to 14 Years
Enrollment: 169 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Ann Arbor, Michigan • New York, New York

Conditions: Obsessive-Compulsive Disorder
Interventions: Tolcapone 200 MG; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Social Anxiety Disorder, Specific Phobia, Separation Anxiety Disorder, Panic Disorder, Agoraphobia, Obsessive-Compulsive Disorder
Interventions: McLean Anxiety Mastery Program; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 6 Years to 19 Years
Enrollment: 559 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Anxiety Disorders in Youth With Autism, Asperger's Syndrome, and Pervasive Developmental Disorder Not Otherwise Specified
Interventions: Cognitive-Behavioral Therapy, Wait-list; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 11 Years to 14 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 2
States / cities: Los Angeles, California • St. Petersburg, Florida

Conditions: Obsessive-Compulsive Disorder
Interventions: Exposure and Response Prevention, OC-Go; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 9 Years to 17 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Bipolar Affective Disorders, Cyclothymic Disorder, Schizoaffective Disorder, Major Depressive Disorder, Dysthymic Disorder, Obsessive-Compulsive Disorder, Panic Disorder, Posttraumatic Stress Disorder, Premenstrual Dysphoric Disorder, Social Anxiety Disorder
Interventions: Not listed
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Anxiety Disorders, Depressive Disorder, Post Traumatic Stress Disorder, Obsessive-Compulsive Disorder
Interventions: Standard UP Treatment, Capitalization UP Treatment, Compensation UP Treatment; Behavioral
Lead sponsor: Shannon E. Sauer-Zavala; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Trichotillomania
Interventions: Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 60 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2014
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Cognitive Behavioral Therapy, Autism Spectrum Disorder, Anxiety Disorder, Obsessive-Compulsive Disorder, Social Anxiety Disorder, Generalized Anxiety Disorder, Specific Phobia
Interventions: Cognitive Behavioral Therapy-Email (iCBT-E), Cognitive Behavioral Therapy-Email and Videoconferencing (iCBT-EV); Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 7 Years to 15 Years
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obsessive-Compulsive Disorder, Tricholemmoma, Skin-Picking
Interventions: Computerized cognitive training, Computerized placebo training; Behavioral
Lead sponsor: University of Wisconsin, Milwaukee; Other
Eligibility: 18 Years to 60 Years
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Tourette's Disorder
Interventions: Omega-3 Fatty Acids, Olive oil; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 6 Years to 18 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Obsessive-compulsive Disorder
Interventions: Cognitive-behavioral therapy, D-cycloserine, Placebo pill; Behavioral · Drug
Lead sponsor: University of South Florida; Other
Eligibility: 8 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: OCD
Interventions: escitalopram, Placebo ( sugar pill); Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Trichotillomania
Interventions: Habit Reversal Training; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 7 Years to 17 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Obsessive Compulsive Disorder (OCD)
Interventions: RG1068 (Synthetic Human Secretin); Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Obsessive-Compulsive Disorder
Interventions: Psilocybin (0.25mg/kg), Niacin (250mg); Drug
Lead sponsor: Yale University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Obsessive-Compulsive Disorder
Interventions: Dorsal medial Prefrontal Cortex intermittent theta burst stimulation, cTBS to ROFC; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 13 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Anxiety
Interventions: Mayo Clinic Anxiety Coach; Device
Lead sponsor: Stephen Whiteside; Other
Eligibility: 7 Years to 17 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obsessive-Compulsive Disorder
Interventions: D-Cycloserine, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 7 Years to 17 Years
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: OCD
Interventions: ERP for Individuals; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obsessive-compulsive Disorders and Symptoms
Interventions: ACT-Focused ERP, TAU-ERP; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Major Depressive Disorder
Interventions: Cognitive Control Tasks and Script Driven Imagery; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Youth Mayo Clinic Anxiety Coach Randomized Controlled Trial

Neuropsychological Profiles of Pediatric Obsessive Compulsive Disorder (OCD)

Task Control Circuit Targets for Obsessive Compulsive Behaviors in Children

Tolcapone in Obsessive Compulsive Disorder

Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment

Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents

Randomized Controlled Trial of Standard ERP and OC-Go

The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels

Transdiagnostic Treatment Personalization

Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania

Internet-Based, Parent-Led Cognitive-Behavioral Therapy for Anxiety in Youth With ASD

Neural Mechanisms of Response Inhibition Training for OCRD

Omega-3 Fatty Acids in Tourette's Disorder

D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder

Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder

Habit Reversal Training for Children and Adolescents With Trichotillomania

Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation

Youth Mayo Clinic Anxiety Coach Pilot Study

2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD

Individual Versus Group Exposure With Response Prevention (ERP) for the Treatment of Obsessive Compulsive Disorder (OCD)

Assessing Models of Exposure Therapy

The Role of Cognitive Control in the Transdiagnostic Conceptualization of "Intrusive Thoughts"